Skip to content
★ Sign in to follow
BL

Brian Lundstrom

Acadia Pharmaceuticals IncInternational Stem Cell Corp
Total declarations
22
Companies
2
▲ Purchases (0 ops.)
—
▼ Sales (16 ops.)
€526k

Latest filing published 21 Dec 2010 for International Stem Cell CORP, €70k.

Insider track record

Disclosed buys
0
Disclosed sells
16
Signal history

No signal scores available.

Brian Lundstrom: trading record in brief

Brian Lundstrom is a declared insider at 2 companies; the most frequent names are Acadia Pharmaceuticals Inc and International Stem Cell Corp. We count 22 filings; the first trade dates from 13 August 2007 and the latest from 17 December 2010.

The open-market record consists of 16 sales worth €526k, with no purchase. Outside the open market, there are 6 option exercises. Since January 2010: no purchases and 1 sale on the market.

The latest filing, published on 21 December 2010, reports an option exercise of €70k in International Stem Cell Corp. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Companies and markets linked to Brian Lundstrom

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations22 total

22 of 22 declarations